Development Advice for CBD Products

Cannabadiol (CBD) products have been in news a lot recently, but what does it take to bring a CBD product to market for an unmet medical need? This webinar will discuss development considerations for CBD and other cannabis-derived products from a clinical, preclinical (pharmacology/toxicology), CMC, and regulatory perspective. The webinar will also review challenges and lessons learned from the development and approval of Epidiolex of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in patients 2 years of age and older.

[@jaromejacksan6934]

I will use Weedborn CBD products this time :)